{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/36699"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/36699","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"The role of IGPR-1 in leukemia cells","abstract":"Leukemia is one of the most deadly diseases, responsible for the highest number of childhood cancer cases. Immunoglobulin-containing and proline-rich receptor-1 (IGPR-1) is a newly identified protein found to play an important role in human colon cancer and angiogenesis. The overall goal of this project was to assess IGPR-1 expression in leukemia cell lines and investigate its possible function in the NF-κB pathway, specifically the role of inhibitor of nuclear factor kappa-B kinase subunit beta (IKKβ) in the phosphorylation of IGPR-1. The NF-κB pathway, among others, plays a critical role in human-T-cell leukemia virus type 1 (HTLV-1) infected T-cells. Our preliminary results indicated that IGPR-1 is expressed in leukemia cell lines at variable levels. Further experiments demonstrated that IKKβ is involved in the phosphorylation of IGPR-1 as treatment of HEK-293 cells ectopically expressing IGPR-1 with an IKKβ inhibitor decreased IGPR-1 phosphorylation at Ser220. Likewise, cells treated with lipopolysaccharide (LPS), which is known to activate IKKβ, also stimulated the phosphorylation of IGPR-1 at Ser220. However, transfection of IGPR-1/HEK293 cells with Tax, an oncogene encoded by HTLV-1, decreased phosphorylation of IGPR-1 at Ser220. Taken together, our data indicates that activation of IKKβ in the NF-κB pathway stimulates phosphorylation of IGPR-1.","abstract_html":"Leukemia is one of the most deadly diseases, responsible for the highest number of childhood cancer cases. Immunoglobulin-containing and proline-rich receptor-1 (IGPR-1) is a newly identified protein found to play an important role in human colon cancer and angiogenesis. The overall goal of this project was to assess IGPR-1 expression in leukemia cell lines and investigate its possible function in the NF-κB pathway, specifically the role of inhibitor of nuclear factor kappa-B kinase subunit beta (IKKβ) in the phosphorylation of IGPR-1. The NF-κB pathway, among others, plays a critical role in human-T-cell leukemia virus type 1 (HTLV-1) infected T-cells. Our preliminary results indicated that IGPR-1 is expressed in leukemia cell lines at variable levels. Further experiments demonstrated that IKKβ is involved in the phosphorylation of IGPR-1 as treatment of HEK-293 cells ectopically expressing IGPR-1 with an IKKβ inhibitor decreased IGPR-1 phosphorylation at Ser220. Likewise, cells treated with lipopolysaccharide (LPS), which is known to activate IKKβ, also stimulated the phosphorylation of IGPR-1 at Ser220. However, transfection of IGPR-1/HEK293 cells with Tax, an oncogene encoded by HTLV-1, decreased phosphorylation of IGPR-1 at Ser220. Taken together, our data indicates that activation of IKKβ in the NF-κB pathway stimulates phosphorylation of IGPR-1.","abstract_has_math":false,"creators":["Wang, Shawn"],"institution":"Boston University","degree_name":"Master of Science","degree_level":"masters","degree_discipline":"Medical Sciences","degree_department":null,"school":null,"contributors":[],"advisors":["Rahimi, Nader","Franzblau, Carl"],"committee_chairs":[],"committee_members":[],"year":2019,"date_issued":"2019","date_published":"2019","updated_at":"2026-11-19T02:41:09Z","subjects":["Biochemistry","IGPR-1","Leukemia"],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2144/36699","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/36699","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F36699","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Rahimi, Nader","Franzblau, Carl"]},{"key":"dc:creator","label":"Author","values":["Wang, Shawn"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2019-07-29T18:40:58Z"]},{"key":"dc:date.embargo","label":"Dc Date Embargo","values":["2020-06-17T00:00:00Z"]},{"key":"dc:date.issued","label":"Date","values":["2019"]},{"key":"dc:date.updated","label":"Dc Date Updated","values":["2019-06-17T19:19:22Z"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Medical Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["masters"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Biochemistry","IGPR-1","Leukemia"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/36699"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Leukemia is one of the most deadly diseases, responsible for the highest number of childhood cancer cases. Immunoglobulin-containing and proline-rich receptor-1 (IGPR-1) is a newly identified protein found to play an important role in human colon cancer and angiogenesis. The overall goal of this project was to assess IGPR-1 expression in leukemia cell lines and investigate its possible function in the NF-κB pathway, specifically the role of inhibitor of nuclear factor kappa-B kinase subunit beta (IKKβ) in the phosphorylation of IGPR-1. The NF-κB pathway, among others, plays a critical role in human-T-cell leukemia virus type 1 (HTLV-1) infected T-cells. Our preliminary results indicated that IGPR-1 is expressed in leukemia cell lines at variable levels. Further experiments demonstrated that IKKβ is involved in the phosphorylation of IGPR-1 as treatment of HEK-293 cells ectopically expressing IGPR-1 with an IKKβ inhibitor decreased IGPR-1 phosphorylation at Ser220. Likewise, cells treated with lipopolysaccharide (LPS), which is known to activate IKKβ, also stimulated the phosphorylation of IGPR-1 at Ser220. However, transfection of IGPR-1/HEK293 cells with Tax, an oncogene encoded by HTLV-1, decreased phosphorylation of IGPR-1 at Ser220. Taken together, our data indicates that activation of IKKβ in the NF-κB pathway stimulates phosphorylation of IGPR-1."]},{"key":"dc:title","label":"Title","values":["The role of IGPR-1 in leukemia cells"]}]}],"canonical_facts":{"dc:contributor.advisor":["Rahimi, Nader","Franzblau, Carl"],"dc:creator":["Wang, Shawn"],"dc:date.accessioned":["2019-07-29T18:40:58Z"],"dc:date.embargo":["2020-06-17T00:00:00Z"],"dc:date.issued":["2019"],"dc:date.updated":["2019-06-17T19:19:22Z"],"dc:description.abstract":["Leukemia is one of the most deadly diseases, responsible for the highest number of childhood cancer cases. Immunoglobulin-containing and proline-rich receptor-1 (IGPR-1) is a newly identified protein found to play an important role in human colon cancer and angiogenesis. The overall goal of this project was to assess IGPR-1 expression in leukemia cell lines and investigate its possible function in the NF-κB pathway, specifically the role of inhibitor of nuclear factor kappa-B kinase subunit beta (IKKβ) in the phosphorylation of IGPR-1. The NF-κB pathway, among others, plays a critical role in human-T-cell leukemia virus type 1 (HTLV-1) infected T-cells. Our preliminary results indicated that IGPR-1 is expressed in leukemia cell lines at variable levels. Further experiments demonstrated that IKKβ is involved in the phosphorylation of IGPR-1 as treatment of HEK-293 cells ectopically expressing IGPR-1 with an IKKβ inhibitor decreased IGPR-1 phosphorylation at Ser220. Likewise, cells treated with lipopolysaccharide (LPS), which is known to activate IKKβ, also stimulated the phosphorylation of IGPR-1 at Ser220. However, transfection of IGPR-1/HEK293 cells with Tax, an oncogene encoded by HTLV-1, decreased phosphorylation of IGPR-1 at Ser220. Taken together, our data indicates that activation of IKKβ in the NF-κB pathway stimulates phosphorylation of IGPR-1."],"dc:identifier.uri":["https://hdl.handle.net/2144/36699"],"dc:language.iso":["en_US"],"dc:subject":["Biochemistry","IGPR-1","Leukemia"],"dc:title":["The role of IGPR-1 in leukemia cells"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Medical Sciences"],"thesis:degree_level":["masters"],"thesis:degree_name":["Master of Science"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-19T02:41:09Z"}